Typologies of Altruistic and Financial Motivations for Research Participation

Journal of Empirical Research on Human Research Ethics

Volumn 11, Issue 4, 2016, Pages 299-310

  Chin, Lisa J ^a   Berenson, Jacqueline A ^b   Klitzman, Robert L ^c  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b Mid Hudson Forensic Psychiatric Institute   (United States)

^c Mail Unit 15 ^*  (United States)

Author keywords

altruism; benefits; compensation; HIV vaccine trial; motivators for participation; risks

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ALTRUISM; ATTITUDE; ETHICS; HUMAN; MALE; MEDICAL RESEARCH; MORALITY; MOTIVATION; PATIENT SELECTION; PHILOSOPHY; REMUNERATION; RESEARCH SUBJECT; RISK; SEXUAL MINORITY; SOCIAL ENVIRONMENT; YOUNG ADULT;

ADULT; AIDS VACCINES; ALTRUISM; ATTITUDE; BIOMEDICAL RESEARCH; HUMANS; MALE; MORALS; MOTIVATION; PATIENT SELECTION; PHILOSOPHY; REMUNERATION; RESEARCH SUBJECTS; RISK; SEXUAL MINORITIES; SOCIAL ENVIRONMENT; YOUNG ADULT;

EID: 85006415555     PISSN: 15562646     EISSN: 15562654     Source Type: Journal    
DOI: 10.1177/1556264616679537     Document Type: Article

References (51)

1. Appelbaum P. S., Roth L. H., Lidz C., (1982). The therapeutic misconception: Informed consent in psychiatric research. International Journal of Law and Psychiatry, 5, 319-329. doi: 10.1177/1740774512456455
2. Aristotle. (2009). Nicomachean ethics (Reeve C. D. C., Trans.). New York, NY: Oxford University Press.
3. Bartholow B. N., MacQueen K. M., Douglas J. M., Buchbinder S., McKirnan D., Judson F. N., (1997). Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. Journal of Acquired Immune Deficiency Syndromes, 16, 108-115. Retrieved from http://journals.lww.com/jaids/Fulltext/1997/10010/Assessment-of-the-Changing-Willingness-to.6.aspx
4. Brooks R. A., Newman P. A., Duan N., Ortiz D. J., (2007). HIV vaccine trial preparedness among Spanish-speaking Latinos in the US. AIDS Care, 19, 52-58. doi: 10.1080/09540120600872711
5. Brown D. R., Fouad M. N., Basen-Engquist K., Tortolero-Luna G., (2000). Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Annals of Epidemiology, 10, S13-S21. Retrieved from http://www.annalsofepidemiology.org/article/S1047-2797%2800%2900197-6/pdf
6. Buchbinder S. P., Mehrotra D. V., Duerr A., Fitzgerald D. W., Mogg R., Li D.,. Robertson M. N., (2008). Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the step study): A double-blind, randomised, placebo-controlled, test-of-concept trial. The Lancet, 372, 1881-1893. doi: 10.1016/S0140-6736(08)61591-3
7. Buchbinder S. P., Metch B., Holte S. E., Scheer S., Coletti A., Vittinghoff E., (2004). Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndromes, 36, 604-612.
8. Cassileth B. R., Lusk E. J., Miller D. S., Hurwitz S., (1982). Attitudes toward clinical trials among patients and the public. Journal of the American Medical Association, 248, 968-970. doi: 10.1001/jama.1982.03330080050028
9. Celentano D. D., Beyrer C., Natpratan C., Eiumtrakul S., Sussman L., Renzullo P. O., (1995). Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS, 9, 1079-1083. Retrieved from http://journals.lww.com/aidsonline/Abstract/1995/09000/Willingness-to-participate-in-AIDS-vaccine-trials.15.aspx
10. Colfax G., Buchbinder S., Vamshidar G., Celum C., McKirnan D., Neidig J.,. Bartholow B., (2005). Motivations for participating in an HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndromes, 39, 359-364.
11. Comté A., (2016). Systeme de politique positive [ System of Postive Politics ]. CreateSpace. Retrieved from: https://www.createspace.com/6008224 (. Accessed 8 November 8, 2016)
12. Corbin J. M., Strauss A. L., (2008). Basics of qualitative research: Techniques and procedures for developing grounded theory. Los Angeles, CA: SAGE.
13. Dhalla S., Poole G., (2011). Motivators of enrolment in HIV vaccine trials: A review of HIV vaccine preparedness studies. AIDS Care, 23, 1430-1447. doi: 10.1080/09540121.2011.555750
14. Dhalla S., Poole G., (2014). Motivators to participation in actual HIV vaccine trials. AIDS and Behavior, 18, 63-277. doi: 10.1007/s10461-013-0519-8
15. Dunn L. B., Kim D. S., Fellows I. E., Palmer B. W., (2009). Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research. Schizophrenia Bulletin, 35, 730-737. doi: 10.1093/schbul/sbn003
16. Fehr E., Fischbacher U., (2003). The nature of human altruism. Nature, 425, 785-791. doi: 10.1038/nature02043
17. Gray K., Legg K., Sharp A., Mackie N., Olarinde F., De Souza C.,. Peters B., (2008). Participation in two phase II prophylactic HIV vaccine trials in the UK. Vaccine, 26, 2919-2924. doi: 10.1016/j.vaccine.2008.03.039
18. Gross M., Seage G. R., Mayer K. H., Goldstein R. S., Losina E., Wold C., (1996). Interest among gay/bisexual men in greater Boston in participating in clinical trials of preventive HIV vaccines. Journal of Acquired Immune Deficiency Syndromes, 12, 406-412.
19. Hallowell N., Cooke S., Crawford G., Lucassen A., Parker M., Snowdon C., (2010). An investigation of patients' motivations for their participation in genetics-related research. Journal of Medical Ethics, 36, 37-45. doi: 10.1136/jme.2009.029264
20. Halpern S. D., Karlawish J. H. T., Casarett D., Berlin J. A., Asch D., (2004). Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Archives of Internal Medicine, 164, 801-803. doi: 10.1001/archinte.164.7.801
21. Harro C. D., Judson F. N., Gorse G. J., Mayer K. H., Kostman J. R., Brown S. J.,. The VAX004 Study Group. (2004). Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndromes, 37, 1385-1392.
22. Hays R. B., Kegeles S. M., (1999). Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials. Journal of Acquired Immune Deficiency Syndromes, 20, 164-171.
23. Hoffman M. L., (1981). Is altruism part of human nature? Journal of Personality and Social Psychology, 40, 121-137. doi: 10.1037/0022-3514.40.1.121
24. Janz N. K., Becker M. H., (1984). The health belief model: A decade later. Health Education Quarterly, 11, 1-47.
25. Jenkins R. A., Temoshok L. R., Virochsiri K., (1992). Incentives and disincentives to participate in prophylactic HIV vaccine research. Journal of Acquired Immune Deficiency Syndromes, official publication of the International Retrovirology Association 9 (1), 36-42.
26. Koblin B. A., Avrett S., Taylor P. E., Stevens C. E., (1997). Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. Journal of Acquired Immune Deficiency Syndromes, 15, 165-171.
27. Koblin B. A., Heagerty P., Sheon A., Buchbinder S., Celum C., Douglas J. M.,. Seage G., (1998). Readiness of high-risk populations in the HIV network for Prevention trials to participate in HIV vaccine efficacy trials in the United States. AIDS, 12, 785-793.
28. Krebs D. L., (1970). Altruism: An examination of the concept and a review of the literature. Psychological Bulletin, 73, 258-302. doi: 10.1037/h0028987
29. Krebs D. L., Van Hesteren F., (1992). The development of altruistic personality. In Oliner P. M., Oliner S. P., Baron L., Blum L., Krebs D. L., Smolenka M. Z., (Eds.), Embracing the other: Philosophical, psychological, and historical perspectives on altruism (pp. 142-169). New York: New York University Press.
30. MacQueen K. M., Vanichseni S., Kitayaporn D., Lin L. S., Buavirat A., Naiwantankul T.,. Mastro T. D., (1999). Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. Journal of Acquired Deficiency Syndromes, 21, 243-251.
31. McGrath J. W., George K., Svilar G., Ihler K., Mafigiri D., Kabugo M., Mugisha E., (2001). Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. Journal of Acquired Immune Deficiency Syndromes, 27, 381-388.
32. Meyers K., Metzger D. S., Navaline H., Woody G. E., McLellan A. T., (1994). HIV vaccine trials: Will intravenous drug users enroll? American Journal of Public Health, 84, 761-766.
33. Miller F. G., Rosenstein D. L., (2003). The therapeutic orientation to clinical trials. New England Journal of Medicine, 348, 1383-1386. doi: 10.1056/NEJMsb030228
34. Monroe K. R., (1994). A fat lady in a corset: Altruism and social theory. American Journal of Political Science, 38, 861-893. doi: 10.2307/2111725
35. Newman P. A., Duan N., Kakinami L., Roberts K., (2008). What can HIV vaccine trials teach us about future HIV vaccine dissemination. Vaccine, 26, 2528-2536. doi: 10.1016/j.vaccine.2008.03.004
36. Newman P. A., Duan N., Roberts K. J., Seiden D., Rudy E. T., Swendeman D., Popova S., (2006). HIV vaccine trial participation among ethnic minority communities: Barriers, motivators, and implications for recruitment. Journal of Acquired Immune Deficiency Syndromes, 41, 210-217. doi: 10.1097/01.qai.0000179454.93443.60
37. Périssé A. R. S., Schechter M., Moriera R. I., do Lago R. F., Santoro-Lopes G., Harrison L. H., (2000). Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndromes, 25, 459-463. doi: 10.1080/0954012031000134773
38. Piliavin J. A., Chaing H.-W., (1990). Altruism: A review of recent theory and research. Annual Review of Sociology, 16, 27-65. Retrieved from http://www.jstor.org/stable/2083262
39. Plato. (2012). The republic (Rowe C., Intro., Trans. and Notes). USA: Penguin Classics.
40. Rand A., (1964). The virtue of selfishness: A new concept of egoism. Penguin.
41. Ruzagira E., Wandlembe S., Bufumbo L., Levin J., Price M. A., Grosskurth H., Kamali A., (2009). Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. Tropical Medicine & International Health, 14, 196-203. doi: 10.1111/j.1365-3156.2008.02200.x
42. Sahay S., Mehendale S., Sane S., Brahme R., Brown A., Charron K.,. Paranjape R., (2005). Correlates of HIV vaccine trial participation: An Indian perspective. Vaccine, 23, 1351-1358. doi: 10.1016/j.vaccine.2004.09.032
43. Schafer A., (1982). The ethics of the randomized clinical trial. New England Journal of Medicine, 307, 719-724. doi: 10.1056/NEJM198209163071204
44. Sengupta S., Strauss R. P., DeVillis R., Quinn S. C., DeVillis B., Ware W. B., (2000). Factors affecting African-American participation in AIDS research. Journal of Acquired Immune Deficiency Syndromes, 24, 275-284.
45. Simon H. A., (1993). Altruism and economics. American Economic Review, 83, 156-161. Retrieved from http://www.jstor.org/stable/2117657?seq=1#page-scan-tab-contents
46. Starace F., Wagner T. M., Luzi A. M., Cafaro L., Gallo P., Rezza G., (2006). Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: Results of a national survey. AIDS Care, 18, 66-72. doi: 10.1080/09540120500161777
47. Strauss R. P., Sengupta S., Kegeles S., McLellan E., Metzger D., Eyre S.,. MacQueen K. M., (2001). Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three U.S. communities. Journal of Acquired Immune Deficiency Syndromes, 26, 63-71.
48. Sugarman J., Kass N. E., Goodman S. N., Perentesis P., Fernandes P., Faden R. R., (1998). What patients say about medical research? IRB: Ethics & Human Research, 20, 1-7. doi: 10.2307/3564262
49. Sullivan J., (2001). Subject recruitment and retention: Barriers to success. Applied Clinical Trials. Retrieved from http://www.appliedclinicaltrialsonline.com/subject-recruitment-and-retention-barriers-success
50. Sutherland H. J., da Cunha R., Lockwood G. A., Till J. E., (1998). What attitudes and beliefs underlie patients' decisions about participating in chemotherapy trials? Medical Decision Making, 18, 61-69. doi: 10.1177/0272989X9801800113
51. Tarimo E. A. M., Thorson A., Kohl T. W., Mwami J., Bakari M., Sandström E., Kulane A., (2010). Balancing collective responsibility, individual opportunities and risks: A qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania. BMC Public Health, 10, Article 292. doi: 10.1186/1471-2458-10-292